US Patent 9902741 Macrocyclic compounds as TRK kinase inhibitors
Patent 9902741 was granted and assigned to Array Biopharma Inc. on February, 2018 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 9902741 Macrocyclic compounds as TRK kinase inhibitors
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
